Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E0YW
|
|||
| Drug Name |
DS-1062
|
|||
| Synonyms |
AUTFGCQEAOOQAR-UHFFFAOYSA-N; ethyl 5-(chloromethyl)-1,2,4-oxadiazole-3-carboxylate; 1009620-97-6; ethyl5-(chloromethyl)-1,2,4-oxadiazole-3-carboxylate; SCHEMBL3214456; KS-00000HYY; CTK3J9399; DTXSID80654863; MolPort-009-199-811; ZINC43220516; CE-804; ANW-49321; SBB091191; AKOS005146382; RP25017; CJ-20372; SC-14657; BR-40600; AN-25976; TC-061709; KB-202058; DB-026590; AJ-108509; KB-111885; AB0001145; FT-0083498; 4CH-008814; X8538; ST24030632; FT-0651464; AM20070658; S-5410; A15053; J-521069; ethyl 5-chloromethyl [1,2,4]oxadiazole-3-carboxylate; I14-10208; Ethyl 5
Click to Show/Hide
|
|||
| Indication | Non-small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162] | Phase 1 | [1] | |
| Company |
Daiichi Sankyo Basking Ridge, NJ
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H7ClN2O3
|
|||
| Canonical SMILES |
CCOC(=O)C1=NOC(=N1)CCl
|
|||
| InChI |
1S/C6H7ClN2O3/c1-2-11-6(10)5-8-4(3-7)12-9-5/h2-3H2,1H3
|
|||
| InChIKey |
AUTFGCQEAOOQAR-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1009620-97-6
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.